Safety and Efficacy of CD207 Targeted CAR-T Cell Therapy in Patients With R/R Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis Intervention: Biological: CD207 CAR-T cells Sponsors: Beijing Friendship Hospital; Beijing Boren Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials